APC Recent Decisions June/July 2022
calcipotriol wynzora tafluprost infliximab dementia donepezil galantamine memantine rivastigmine acenocoumarol sinthrone insulin
calcipotriol wynzora tafluprost infliximab dementia donepezil galantamine memantine rivastigmine acenocoumarol sinthrone insulin
acenocoumarol sinthrone guanfacine intuniv somatropin saizen easypod liothyronine testosterone testogel empagliflozin dapagliflozin heart failure HF anticoagulation NVAF atrial fibrillation AF edoxaban DOAC nutrition food first… Read More »APC Recent Decisions May 2022
Melatonin adaflex alfentanil fixapost tiopex timolol fidaxomicin forceval junior
otigo otitis media phenazone hayfever allergic rhinitis allergy rifaximin denosumab prolia osteoporosis alprostadil aviptadil phentolamine invicorp vitaros edoxaban liothyronine T3 thyroid
Tolterodine trospium inclisiran HRT bimekizumab epistatus midazolam co-enzyme Q10 ubidecarenone ubiquinone rivaroxaban Xarelto paxlovid ciprofloxacin eardrops diprobase limbo sealtight waterproof
actinic solar keratosis melatonin bempedoic goserelin leuprorelin zoladex prostap paxlovid delstrigo metvix chloramphenicol thyroid extract ephedrine
COPD rescue rescue pack inhaler ons nutrition supplement ensure aymes altraplen fortisip trimbow nexthaler tirbanibulin klisyri actinic keratosis keratoses molnupiravir lagevrio sotrovimab xevudy plerixafor dexamethasone… Read More »APC Recent Decisions December 2021
midazolam buccal oromucosal epistatus buccolam status epilepticus methenamine hiprex levofloxacin dapagliflozin forxiga indocyanine shortage environment blueteq device
Inclisiran Postural hypotention acne vulgaris trimethoprim benzoyl peroxide/clindamycin azelaic acid cream testosterone menopause melotoinin cluster headaches donepezil dantrolene emerade diazepam ivermectin
hyperlipidaemia hyperchhyperlipidaemia hypercholesterolaemia Leqvio lipid